Cargando…
Absolute lymphocyte count and C-reactive protein-albumin ratio can predict prognosis and adverse events in patients with recurrent esophageal cancer treated with nivolumab therapy
Predicting the prognosis and adverse events (AEs) of nivolumab therapy for recurrent esophageal cancer is very important. The present study investigated whether a simple blood biochemical examination could be used to predict prognosis and AEs following nivolumab treatment for relapse of esophageal c...
Autores principales: | Inoue, Hiroyuki, Shiozaki, Atsushi, Fujiwara, Hitoshi, Konishi, Hirotaka, Kiuchi, Jun, Ohashi, Takuma, Shimizu, Hiroki, Arita, Tomohiro, Yamamoto, Yusuke, Morimura, Ryo, Kuriu, Yoshiaki, Ikoma, Hisashi, Kubota, Takeshi, Okamoto, Kazuma, Otsuji, Eigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219019/ https://www.ncbi.nlm.nih.gov/pubmed/35765281 http://dx.doi.org/10.3892/ol.2022.13377 |
Ejemplares similares
-
Predictors of the difficulty of transcervical subcarinal lymph node dissection for esophageal cancer
por: Furuke, Hirotaka, et al.
Publicado: (2023) -
Evaluation of subcarinal lymph node dissection and metastasis in transmediastinal radical esophagectomy
por: Shibamoto, Jun, et al.
Publicado: (2021) -
Postoperative liver dysfunction is associated with poor long-term outcomes in patients with colorectal cancer: a retrospective cohort study
por: Sumiyoshi, Shutaro, et al.
Publicado: (2023) -
Clinical impact of postoperative interval until adjuvant chemotherapy following curative gastrectomy for advanced gastric cancer
por: Takashima, Yusuke, et al.
Publicado: (2021) -
Clinical safety and efficacy of neoadjuvant combination chemotherapy of tranilast in advanced esophageal squamous cell carcinoma: Phase I/II study (TNAC)
por: Shiozaki, Atsushi, et al.
Publicado: (2020)